Trial Profile
A phase 1, open-label, randomized, two-way crossover study to evaluate the effect of multiple doses of fidaxomicin on the single dose pharmacokinetics of rosuvastatin in healthy male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Sep 2016
Price :
$35
*
At a glance
- Drugs Fidaxomicin (Primary) ; Rosuvastatin (Primary)
- Indications Clostridium difficile infections
- Focus Pharmacokinetics
- Sponsors Astellas Pharma Europe Ltd
- 14 Mar 2014 New trial record